Prescription status of edaravone and personal importation: Notice of update

Organizations and the provinces/territories continue to make progress in the marketing and reimbursement of edaravone (brand name Radicava). Currently, all provinces with the exception of Prince Edward Island (PEI) have updated their drug formularies to include edaravone for public reimbursement. The territories are still in the process of establishing full coverage.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-12-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data